The increase in Lyme disease cases during the last decade has prompted its classification as an "emerging" infectious disease. The bacterium Borrelia Burgdorferi from an infected deer tick is believed to be the main cause of Lyme Disease.
Individuals affected by "chronic Lyme Disease" or "Post-treatment Lyme Disease Syndrome" are facing three main concerns:
A safe and effective way to help restore the health and quality of life of those with this degenerative disease is to address the three aspects of the disease in parallel. Natural antibiotic therapies and detoxification protocols for bacterium, biofilms, and heavy metals are used in conjunction with regenerative medicine in the form of pluripotent stem cell therapy as an effective treatment against the disease.
Our treatment plans generally last between 2 and 5 weeks, depending on your overall health, your condition, and the severity of your Lyme disease symptoms. Anyone can sign up for stem cell treatment for Lyme disease. Each stem cell treatment candidate will receive a tailored plan to help achieve the highest success rate for maximum therapy efficiency. Typically, stem cell therapy for Lyme disease will resemble a program such as the one below, and will last for 4 weeks.
24 Stem cell IV’s
24 Day anti-bacterial treatment
10 IVs
4 sessions
Because we utilize a type of stem cell type that is cultured in our laboratory, rather than using mesenchymal stem cells (adult stem cells) coming from the patient's bone marrow or adipose tissue, we completely avoid the potential risks associated with invasive cell-removal procedures.
Pluripotent stem cell injections are a safe treatment that have the immediate effect of strengthening the immune system. Considerable improvement is also observed in the joint inflammation within four weeks of the treatment. Chronic Lyme disease patients who receive stem cell therapy may also experience improvement in energy levels, strength, motivation, and balance during that period of time.
The first benefit from the stem cell treatments is an improvement in immune deficiencies - an increased capacity of the body to defend itself from the pathogen invasion.
The second level of improvement in the Lyme disease patient receiving stem cell treatment is usually observed after a minimum of 3 injections when the diseased tissue, and different organs that have been damaged by the disease start to show signs of repair. Pluripotent stem cells are especially efficient at reversing brain neurological problems.
Lyme disease patients on anti-depressants were able to cease taking them when entering the 4th week after the treatment. Some showed improvements a little later but most patients show remarkable improvement in symptoms of the neurological kind.
Clinical improvement is also observed in the joint inflammation, reducing chronic pain within 4 weeks of the "alternative treatments" using stem cells.
1. Lyme disease treatment | CDC
2. Transplantation of Human Embryonic Stem Cells in Patients with Multiple Sclerosis and Lyme Disease
3. Improvement of common variable immunodeficiency using embryonic stem cell therapy in a patient with lyme disease: a clinical case report
4. Single-photon emission tomography imaging in patients with Lyme disease treated with human embryonic stem cells
5. Treatment of Lyme Disease with Human Embryonic Stem Cells: A Case Series | OMICS International | Abstract
6. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors - PubMed
7. Reprogramming to recover youthful epigenetic information and restore vision - PubMed
8. In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice - Nature Aging
9. Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells
10. Lyme Disease Treatment & Management: Approach Considerations, Treatment of Early Lyme Disease, Lyme Arthritis
11. Time for a Different Approach to Lyme Disease and Long-Term Symptoms | NEJM